Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program.

What Was Tested

This controlled clinical trial looks at Buserelin.

To investigate the effect of salpingectomy on the response of each ovary in patients undergoing an IVF-ET treatment cycle and to compare the results with those of patients who had not had surgery and were undergoing IVF-ET during the same period.

Who Took Part

The study group was 29 patients.

The age groups tagged for this paper are adults, women only.

Twenty-nine ET cycles were evaluated in 29 patients who previously had undergone unilateral salpingectomy because of ectopic pregnancy (study group).

Seventy-three patients with unexplained or male factor infertility served as controls.

How the Study Was Run

Tertiary referral academic IVF unit.

What Was Measured

PubMed files the paper under topics including Buserelin, Chorionic Gonadotropin, Embryo Transfer, Fallopian Tubes, Fertility Agents, Female, Fertilization in Vitro and Ovary.

What This Means in Plain Language

This is a controlled clinical trial of Buserelin in 29 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 1998 (Fertility and sterility), a journal based in United States.

More context: all human trials.